Latest News in the pharma Industry

All

Sandoz proposed biosimilars adalimumab and infliximab accepted for regulatory review by the EMA

Sandoz proposed biosimilars adalimumab and infliximab accepted for regulatory review by the EMA

31 May 2017

Biosimilar infliximab alone could potentially save the NHS £89 million.

Read more 
Vetter and Microdermics to develop innovative microneedle drug delivery systems

Vetter and Microdermics to develop innovative microneedle drug delivery systems

31 May 2017

Microdermics has successfully demonstrated the initial safety of its microneedle system, and is planning Phase I human clinical trials for vaccine and therapeutic delivery, to be initiated in 2017.

Read more 
Synimmune initiates FiH study of Fc-optimized antibody Flysyn for the treatment of AML

Synimmune initiates FiH study of Fc-optimized antibody Flysyn for the treatment of AML

31 May 2017

Flysyn is the first antibody from the company's pipeline to be tested in humans.

Read more 
Marken Launches Hybrid Clinical Trials Service

Marken Launches Hybrid Clinical Trials Service

30 May 2017

Marken today announced it has launched a new hybrid logistics service which leverages the UPS global transportation network, and has already received customer commitments for the new service. The hybrid service enables Marken to utilize the UPS network...

Read more 
Cambrex invests in new capacity and continuous flow technology at its Karlskoga, Sweden facility

Cambrex invests in new capacity and continuous flow technology at its Karlskoga, Sweden facility

30 May 2017

The expansion is part of an ongoing strategic campaign to invest in small molecule API manufacturing across the company's global network of facilities.

Read more 
Sanner acquisition strengthens company's leadership in effervescent packaging market

Sanner acquisition strengthens company's leadership in effervescent packaging market

30 May 2017

Acquisition of Jaco enables Sanner to operate as a system supplier.

Read more 
Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services

Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services

30 May 2017

Under the terms of this new agreement, PCT will provide GMP-compliant manufacturing services for Orchard’s lead product, OTL-101, an autologous ex-vivo gene therapy for the treatment of ADA-SCID.

Read more 
Hookipa Biotech announces data showing TheraT turns cold tumours hot

Hookipa Biotech announces data showing TheraT turns cold tumours hot

30 May 2017

TheraT mediated alarmin release crucial for active immunization in cancer immunotherapy.

Read more 
Recipharm makes strategic appointment in the UK & Ireland

Recipharm makes strategic appointment in the UK & Ireland

30 May 2017

Shabbir Mostafa to join the CDMO as Director, Business Management, with responsibility for driving sales of Recipharm’s manufacturing services.

Read more 
Lupin Pharmaceuticals announces nationwide recall of Mibelas 24 Fe tablets

Lupin Pharmaceuticals announces nationwide recall of Mibelas 24 Fe tablets

30 May 2017

Recall due to out of sequence tablets and missing expiry/lot information.

Read more 
FDA accepts for priority review BMS’s application for Opdivo in previously treated hepatocellular carcinoma

FDA accepts for priority review BMS’s application for Opdivo in previously treated hepatocellular carcinoma

26 May 2017

Application is based on results from the Phase I/II CheckMate -040 trial.

Read more 
Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

26 May 2017

Amongst highest levels of immune responses ever demonstrated in an HIV vaccine human study.

Read more